Home > Healthcare > Healthcare IT > Payer/Provider Solutions > Digital Diabetes Management Market

Digital Diabetes Management Market Size

  • Report ID: GMI4903
  • Published Date: Jun 2023
  • Report Format: PDF

Digital Diabetes Management Market Size

Digital Diabetes Management Market size was worth USD 18.9 billion in 2022. Driven by the rising prevalence of diabetes globally, the industry could grow at 20% CAGR from 2023 to 2032.

 

Growing adoption of a sedentary lifestyle, poor eating habits, and rising cases of obesity have increased the occurrence of diabetes, increasing the demand for digital diabetes management for remote patient monitoring. As per the International Diabetes Federation, in 2021, the global diabetes prevalence in people aged between 20 to 79 years was 10.5% (536.6 million people), which is projected to reach around 783 million people by 2045.

 

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

In 2022, the digital diabetes management industry was valued at USD 18.9 billion and will grow at 20% CAGR from 2023 to 2032, attributed to the growing prevalence of diabetes globally.

The market share from the services segment will grow at more than 18.5% CAGR from 2023 to 2032, owing to rapid advancements in diabetes management software and apps.

North America digital diabetes management market size reached over USD 6 billion in 2022, attributed to the favorable government initiatives for diabetes treatment.

Major digital diabetes management industry players include Abbott Laboratories, F.Hoffmann-La Roche Ltd, Senseonics, Tandem Diabetes Care, Inc, Medtronic Plc, Dexcom, Inc, and Insulet Corporation, among others.

Digital Diabetes Management Market Scope

Buy Now


Premium Report Details

  • Base Year: 2022
  • Companies covered: 15
  • Tables & Figures: 366
  • Countries covered: 19
  • Pages: 260
 Download Free Sample